Cis-Diamminebichloroplatinum as a Therapeutic Agent in Metastatic Transitional Cell Carcinoma
Authors:
- 1 March 1980
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 123 (3) , 375-377
Abstract
Cis-platinum as single agent therapy was investigated in 8 patients with stage D transitional cell carcinoma of the bladder. Dramatic responses were obtained in some patients and the quality of life was improved for as long as 8 mo. but no cures were obtained. Also noted was an occasional marked loss of renal function as measured by creatinine clearance despite a carefully managed protocol to avert this known side effect of cis-platinum (nephrotoxicity). No auditory problems were noted in these 8 patients.Keywords
This publication has 2 references indexed in Scilit:
- Cis-diamminedichloroplatinum II in Advanced Urothelial CancerJournal of Urology, 1978
- Treatment of Advanced Bladder Cancer with Cis-Diamminedichloroplatinum (II NSC 119875): A Pilot StudyJournal of Urology, 1978